Both MLH1-deficient patients (P7 and P8) had T-NHL at a very early age (8 months and 1 year), and P7 developed another lymphoma (B-NHL) at 12 years of age, a borderline phylloides tumor at 16 and a glioblastoma at 21. Here, MLH1 is linked to neoplasm.